The Weekly Roundup: March 27-31

Author(s):

ICYMI, this week we had stories about session highlights from AAD 2023, FDA approvals of biosimilars and MCC treatments, the association between the Mediterranean diet and tumor response rates, and more.

POLL: What Topics Did You Most Enjoy at AAD 2023?

Click here to answer this week's poll.

Lanolin Named Allergen of the Year

Although the ingredient is widely used in skincare, the American Contact Dermatitis Society (ACDS) wants clinicians to take special considerations when patch testing for lanolin contact allergy.

Risankizumab Efficacious in Clearing, Improving Plaque Psoriasis

AbbVie announced study results demonstrating efficacy in patients with a history of previous interleukin-17 inhibitor therapy.

Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD

Late-breaking positive phase 2a results were presented at AAD 2023.

Self-Esteem in Males with Alopecia Improved by Hair Transplantation

Researchers determined a statistically significant improvement to patient quality of life post-transplant.

Recent Povorcitinib 2b Study Shows Improved Repigmentation

The investigational oral JAK1 inhibitor showed promising results for vitiligo patients.

Jonathan Silverberg Discusses Role of Environment on Atopic Dermatitis

Silverberg discusses how certain irritants and living situations may cause flares in patients with atopic dermatitis.

Adel Haque, MD, Provides His Best Advice for New Dermatologists

Learning how to prescribe biologics, talking to mentors, reviewing journals, and getting involved in clinical trials are all ways to boost your expertise.

5 Perspectives on Laser Treatment in Dermatology

Check out new, trending, and up-and-coming perspectives on the use of laser therapies in several dermatologic conditions.

Breast Care for Pregnant and Lactating Patients

When a patient complains of breast pain, there are several special considerations for diagnosis and treatment.

Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug

There are currently no FDA approved therapies in this treatment setting.

Botulinum Toxin Type A Unparallel Improvements to Skin Quality

Researchers investigated the injection’s impact on the upper face.

EON Gains FDA Clearance for Back and Thighs

The robotic device was previously cleared to treat patients' full abdomen and flanks.

Pointers With Portela: Sun Damage Repair Products

In this week’s Pointers with Dr Portela, the 208SkinDoc picks his top products for repairing sun-damaged skin.

Silybum Marianum Fruit Extract Safe, Effective in Acne-Prone Skin

Researchers say adolescents and young adults using the dermocosmetic product experienced improvements in their acne and quality of life.

Dupilumab Safe and Effective in Moderate-to-Severe Atopic Dermatitis

In a clinical study conducted in Japan, researchers found the treatment well-tolerated and efficacious in moderate-to-severe cases.

New Technology to Assist in Practice Management

The device, produced by Sensus Healthcare, is cloud-based and utilizes OpenAI technology.

Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

In the final part of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.